SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt Diag Hld Regulatory News (IDHC)

Share Price Information for Int Diag Hld (IDHC)

Share Price is delayed by 15 minutes
Get Live Data
0.53    0.00 (0.00%)
Bid:
0.53
Ask:
0.548
Spread: 0.018 (3.396%)
Market Cap: $308.10m
IDHC Live PriceLast checked at - London Stock Exchange

Intraday Int Diag Hld Share Chart

Final dividend clarification

9 Jul 2021 16:16

RNS Number : 8200E
Integrated Diagnostics Holdings PLC
09 July 2021
 

Integrated Diagnostics Holdings plc

(the "Company")

 

Final dividend clarification

 

9 July 2021

 

(Cairo and London) - In reference to resolution 10 approved by shareholders at the Annual General Meeting (AGM) of the Company held on 30 June 2021, the Company notes that the final dividend to be distributed on 29 July 2021 amounts to US$ 29.1 million in aggregate for the year ended 31 December 2020 (as previously stated in the FY2020 and 1Q2021 results announcements issued on 19 May 2021 and 2 June 2021, respectively). This equates to a dividend of US$ 0.0485 per share (due to an administrative oversight the figure was rounded to three rather than four decimal places to US$ 0.049 in the AGM Circular and Summary of Proxy Voting documents issued on 7 June 2021 and 30 June 2021, respectively), and is 4% higher than the US$ 28.0 million in aggregate distributed in the previous financial year.

 

 

-Ends-

 

About Integrated Diagnostics Holdings (IDH)

IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Group's core brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan) and Echo-Lab (Nigeria). A long track record for quality and safety has earned the Company a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 2,000 diagnostics tests. From its base of 483 branches as of 31 March 2021, IDH will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. Beyond organic growth, the Group's expansion plans include acquisitions in new Middle Eastern, African, and Asian markets where its model is well-suited to capitalise on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity with a Standard Listing on the Main Market of the London Stock Exchange (ticker: IDHC) since May 2015 with a secondary listing on the EGX since May 2021 (ticker: IDHC.CA). Learn more at idhcorp.com.

 

The person responsible for arranging the release of this announcement is Nancy Fahmy, Investor Relations Director at IDH.

 

Contact

Nancy Fahmy

Investor Relations Director

T: +20 (0)2 3345 5530 | M: +20 (0)12 2255 7445 | nancy.fahmy@idhcorp.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVUPUCGMUPGGAB
Date   Source Headline
28th May 20205:11 pmRNSAnnual Financial Report & Notice of AGM
28th Apr 20207:00 amRNSFinal Results
24th Apr 202011:26 amRNSNotice of Results
25th Mar 20207:00 amRNSCovid-19 Trading Update
23rd Mar 20207:00 amRNSDelay of results pursuant to request of FCA
20th Mar 20203:03 pmRNSNotice of Results
19th Mar 20204:37 pmRNSPrice Monitoring Extension
10th Mar 202010:10 amRNSNotice of Results
13th Jan 20204:40 pmRNSSecond Price Monitoring Extn
13th Jan 20204:35 pmRNSPrice Monitoring Extension
20th Dec 20197:00 amRNSChange of Adviser
10th Dec 201912:47 pmRNSTR1 Notification
5th Dec 20194:35 pmRNSPrice Monitoring Extension
27th Nov 20197:00 amRNS3rd Quarter Results
16th Oct 20194:40 pmRNSSecond Price Monitoring Extn
16th Oct 20194:35 pmRNSPrice Monitoring Extension
10th Sep 20197:00 amRNSHalf-year Report
9th Sep 201910:19 amRNSNotice of Results - Analysts Invitation
28th Aug 20194:40 pmRNSSecond Price Monitoring Extn
28th Aug 20194:35 pmRNSPrice Monitoring Extension
27th Aug 20194:41 pmRNSSecond Price Monitoring Extn
27th Aug 20194:35 pmRNSPrice Monitoring Extension
13th Aug 20193:40 pmRNSNotice of Results
12th Jun 20194:41 pmRNSSecond Price Monitoring Extn
12th Jun 20194:35 pmRNSPrice Monitoring Extension
15th May 201912:21 pmRNSReplacement - 1st Quarter Results
15th May 20197:00 amRNS1st Quarter Results
14th May 20194:14 pmRNSResult of AGM
18th Apr 20195:42 pmRNSAnnual Financial Report & Notice of AGM
21st Mar 20197:00 amRNSFinal Results
7th Mar 20197:00 amRNSAppointment of a Broker
5th Mar 20197:00 amRNSNotice of Results
1st Mar 20194:09 pmRNSHolding(s) in Company
31st Dec 20181:27 pmRNSHolding(s) in Company
17th Dec 20189:06 amRNSAgreement with Georgia Healthcare Group
21st Nov 20187:00 amRNS3rd Quarter Results
7th Sep 20184:40 pmRNSSecond Price Monitoring Extn
7th Sep 20184:35 pmRNSPrice Monitoring Extension
16th Aug 20187:00 amRNSHalf-year Report
14th Aug 20189:46 amRNSLaunch of radiology business in Egyptian market
9th Aug 20184:35 pmRNSPrice Monitoring Extension
5th Jul 20184:35 pmRNSPrice Monitoring Extension
15th May 20187:00 amRNSTrading Statement
14th May 20184:25 pmRNSResult of AGM
11th May 20184:46 pmRNSHolding(s) in Company
25th Apr 20184:35 pmRNSPrice Monitoring Extension
19th Apr 20185:04 pmRNSAnnual Financial Report & Notice of AGM
12th Apr 201812:08 pmRNSSecond Price Monitoring Extn
12th Apr 201812:02 pmRNSPrice Monitoring Extension
9th Apr 201812:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.